H. Lundbeck AS (OCSE:HLUN B) Days Sales Outstanding : 61.34 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Days Sales Outstanding?

H. Lundbeck AS's average Accounts Receivable for the three months ended in Mar. 2024 was kr3,555 Mil. H. Lundbeck AS's Revenue for the three months ended in Mar. 2024 was kr5,288 Mil. Hence, H. Lundbeck AS's Days Sales Outstanding for the three months ended in Mar. 2024 was 61.34.

The historical rank and industry rank for H. Lundbeck AS's Days Sales Outstanding or its related term are showing as below:

OCSE:HLUN B' s Days Sales Outstanding Range Over the Past 10 Years
Min: 51.69 Med: 58.09 Max: 74.39
Current: 70.66

During the past 13 years, H. Lundbeck AS's highest Days Sales Outstanding was 74.39. The lowest was 51.69. And the median was 58.09.

OCSE:HLUN B's Days Sales Outstanding is ranked better than
51.05% of 999 companies
in the Drug Manufacturers industry
Industry Median: 71.45 vs OCSE:HLUN B: 70.66

H. Lundbeck AS's Days Sales Outstanding declined from Mar. 2023 (62.28) to Mar. 2024 (61.34).

H. Lundbeck AS Days Sales Outstanding Historical Data

The historical data trend for H. Lundbeck AS's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Days Sales Outstanding Chart

H. Lundbeck AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

58.16

54.95

56.12

51.69

52.00

H. Lundbeck AS Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															62.28	77.49	75.78	63.96	61.34

Competitive Comparison of H. Lundbeck AS's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, H. Lundbeck AS's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

H. Lundbeck AS's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, H. Lundbeck AS's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where H. Lundbeck AS's Days Sales Outstanding falls into.

H. Lundbeck AS Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

H. Lundbeck AS's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (2709	+	2965)	/	2 )	/	19912	*	365
=	2837					/	19912	*	365
=	52.00

H. Lundbeck AS's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (2965	+	4144)	/	2 )	/	5288	*	365 / 4
=	3554.5					/	5288	*	365 / 4
=	61.34

H. Lundbeck AS (OCSE:HLUN B) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

H. Lundbeck AS Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

H. Lundbeck AS (OCSE:HLUN B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (OCSE:HLUN B) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

HLBBF:USA HLUBF:USA 0ABR:UK 0ND5:UK HLUN A:Denmark LDBA:Germany

Address

Ottiliavej 9, Valby, DNK, 2500

Website

https://www.lundbeck.com

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS (OCSE:HLUN B) Headlines

No Headlines